Quinn Opportunity Partners LLC Relay Therapeutics, Inc. Transaction History
Quinn Opportunity Partners LLC
- $1.08 Billion
- Q2 2025
A detailed history of Quinn Opportunity Partners LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Quinn Opportunity Partners LLC holds 10,000 shares of RLAY stock, worth $32,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$32,200% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RLAY
# of Institutions
224Shares Held
164MCall Options Held
153KPut Options Held
49.2K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$89.9 Million0.67% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct10.8MShares$34.9 Million0.07% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$33.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.38MShares$30.2 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY9.1MShares$29.3 Million2.79% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $387M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...